Cargando…
Effect of DLK1 on tumorigenesis in CD34(+)CD38(−) bone marrow cells in myelodysplastic syndromes
The myelodysplastic syndromes (MDSs) are a group of clonal stem cell disorders resulting from aberrations within hematopoietic stem cells (HSCs), which may lead to the onset of a number of diseases, including acute myeloid leukemia (AML). Recent studies have demonstrated that the expression levels o...
Autores principales: | ZHANG, WEI, SHAO, ZONGHONG, FU, RONG, WANG, HUAQUAN, LI, LIJUAN, YUE, LANZHU |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742462/ https://www.ncbi.nlm.nih.gov/pubmed/23946804 http://dx.doi.org/10.3892/ol.2013.1346 |
Ejemplares similares
-
Abnormal Ferroptosis in Myelodysplastic Syndrome
por: Lv, Qi, et al.
Publicado: (2020) -
Increased Circulating of CD54(high)CD181(low) Neutrophils in Myelodysplastic Syndrome
por: Yang, Liyan, et al.
Publicado: (2021) -
Altered follicular helper T cell impaired antibody production in a murine model of myelodysplastic syndromes
por: Jiang, Huijuan, et al.
Publicado: (2017) -
Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance
por: Yue, Lan-zhu, et al.
Publicado: (2012) -
Case Report: Sirolimus Alleviates Persistent Cytopenia After CD19 CAR-T-Cell Therapy
por: Xing, Limin, et al.
Publicado: (2021)